hair
hair

FDA Sends Warning Letter to Brazilian Blowout

The U.S. Food and Drug Administration has demanded that the company correct the “misbranding” of its controversial hair-straightening products.

News from WWD
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

LatestPublications
getIsArchiveOnly= hasAccess=false hasArchiveAccess=false